Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia or Localized B-lineage Lymphoblastic Lymphoma

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

Trial Name

Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)

What is the trial about?

Collect information about child's leukemia and about the effects of the first phase of treatment called Induction.

Who can participate?

> 365 days and < 10 years of age (for B-ALL patients) / >365 days and ≤ 30.99 years of age (for B-Lly patients).

What is involved?

Induction therapy will last 4 weeks. Tests and procedures include standard cancer care treatment.

Contact Nemours Clinical Trials

Trial Name: Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)

COG#: AALL0932

Contact Information

(800) 354-5690
clinicaltrials@nemours.org